Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging

NCT02818179 — Not applicable, Unknown, 100 participants, Sheba Medical Center

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02818179
StatusUnknown
PhaseNot applicable
Study typeInterventional; na, single group, masking: none
Enrollment100 (Estimated)
SponsorSheba Medical Center (Other gov)
ConditionsMALIGNANCY
InterventionsTHERMOGRAPHY IMAGING (Radiation)
Datesstart 2016-12-01, primary completion 2017-07-01 (estimated), completion 2017-07-01 (estimated), first posted 2016-06-29, last updated 2016-10-14

Related Papers Related Patents Related Grants Related Experts
All trials for MALIGNANCY All trials of THERMOGRAPHY IMAGING

-Summary

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.

In addition, normal tissue response to radiation therapy in treated organ will be evaluated.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Patients undergoing radiationOtherRadiation: THERMOGRAPHY IMAGINGIn this study, patients undergoing radiation treatment will undergo thermography imaging during radiation treatment course. Patients will be evaluated with thermography imaging every week during the brachytherapy treatment for 5 procedures
  • THERMOGRAPHY IMAGING (Radiation)

+Outcome measures

Primary outcomes

  • The change in Infra-Red radiation emitted at wavelengths 0.8-1nm [Baseline and 4 weeks]: Measurement of IR

Secondary outcomes

  • Evaluating of efficacy of the radiation [3 months after the treatment]: The thermal and the optic imaging will be taken and analyzed in order to evaluate the changing in the temperature of the cervix comparing to the baseline as the indication of the response to the radiotherapy

+Eligibility

Sex: Female, ages: 18 Years to 90 Years

Inclusion Criteria:

* signed informed consent
* biopsy proven cervical cancer which will undergo definitive radiation

Exclusion Criteria:

* not eligible to sign informed consent